Tags

Type your tag names separated by a space and hit enter

Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
MMWR Morb Mortal Wkly Rep 1999; 48(26):563-5MM

Abstract

The Food and Drug Administration (FDA) Modernization Act of 1997 called for FDA to review and assess the risk of all mercury-containing food and drugs. In line with this review, U.S. vaccine manufacturers responded to a December 1998 and April 1999 FDA request to provide more detailed information about the thimerosal content of their preparations that include this compound as a preservative. Thimerosal has been used as an additive to biologics and vaccines since the 1930s because it is very effective in killing bacteria used in several vaccines and in preventing bacterial contamination, particularly in opened multidose containers. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal.

Authors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10418806

Citation

Centers for Disease Control and Prevention (CDC). "Thimerosal in Vaccines: a Joint Statement of the American Academy of Pediatrics and the Public Health Service." MMWR. Morbidity and Mortality Weekly Report, vol. 48, no. 26, 1999, pp. 563-5.
Centers for Disease Control and Prevention (CDC). Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999;48(26):563-5.
Centers for Disease Control and Prevention (CDC). (1999). Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR. Morbidity and Mortality Weekly Report, 48(26), pp. 563-5.
Centers for Disease Control and Prevention (CDC). Thimerosal in Vaccines: a Joint Statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999 Jul 9;48(26):563-5. PubMed PMID: 10418806.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. A1 - ,, PY - 1999/7/27/pubmed PY - 1999/7/27/medline PY - 1999/7/27/entrez SP - 563 EP - 5 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 48 IS - 26 N2 - The Food and Drug Administration (FDA) Modernization Act of 1997 called for FDA to review and assess the risk of all mercury-containing food and drugs. In line with this review, U.S. vaccine manufacturers responded to a December 1998 and April 1999 FDA request to provide more detailed information about the thimerosal content of their preparations that include this compound as a preservative. Thimerosal has been used as an additive to biologics and vaccines since the 1930s because it is very effective in killing bacteria used in several vaccines and in preventing bacterial contamination, particularly in opened multidose containers. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal. SN - 0149-2195 UR - https://www.unboundmedicine.com/medline/citation/10418806/Thimerosal_in_vaccines:_a_joint_statement_of_the_American_Academy_of_Pediatrics_and_the_Public_Health_Service_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4826a3.htm DB - PRIME DP - Unbound Medicine ER -